Caption Management, LLC G1 Therapeutics, Inc. Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $193,461 - $437,926	87,937 Added 90.13%	185,505 $422,000
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $204,892 - $471,253	97,568 New	97,568 $421,000
Q1 2020 May 15, 2020	SELL	$9.07 - $26.32 $256,399 - $744,040	-28,269 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$20.54 - $31.0 $580,645 - $876,339	28,269 New	28,269 $748,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.